Date Range
toReport Types
Condition
See all (5)
Specialties
See all (18)
Emerging Treatments
OE Recommends Topics
Multimedia
Journal
Conference Series
Evidence Series
Etanercept with methotrexate more effectively maintains low disease activity in RA
Lancet. 2013 Mar 16;381(9870):918-29. doi: 10.1016/S0140-6736(12)61811-X. Epub 2013 Jan 17
Juvenile RA: Fewer disease flares with Adalimumab (TNF Antibody)
N Engl J Med. 2008 Aug 21;359(8):810-20
Osteosarcoma: methotrexate & doxorubicin versus methotrexate, etoposide & ifosfamide
Eur J Cancer. 2007 Mar;43(4):752-61. Epub 2007 Jan 30
TNF antagonist better in treatment of early rheumatoid arthritis
Lancet. 2009 Aug 8;374(9688):459-66.
RA: Addition of etanercept to methotrexate increases remission rates
Lancet. 2008 Aug 2;372(9636):375-82. Epub 2008 Jul 16
Ifosfamide not necessary in chemotherapy for nonmetastatic osteosarcoma
J Clin Oncol. 2012 Jun 10;30(17):2112-8. doi: 10.1200/JCO.2011.38.4420. Epub 2012 May 7
Tocilizumab more effective in reducing rheumatoid arthritis symptoms than adalimumab
Lancet. 2013 May 4;381(9877):1541-50. doi: 10.1016/S0140-6736(13)60250-0. Epub 2013 Mar 18
Muramyl tripeptide in chemotherapy improves overall osteosarcoma survival
J Clin Oncol. 2008 Feb 1;26(4):633-8. doi: 10.1200/JCO.2008.14.0095
Rheumatoid arthritis: Improvement in clinical outcome similar between 4 drug therapies
Ann Intern Med. 2007 Mar 20;146(6):406-15
MTP-PE added to chemotherapy did not improve outcomes in metastatic osteosarcoma patients
Cancer. 2009 Nov 15;115(22):5339-48. doi: 10.1002/cncr.24566
Osteosarcoma: 25 year survival rate significantly improved with adjuvant chemotherapy
Cancer. 2012 Dec 1;118(23):5888-93
Tocilizumab treatment in systemic juvenile idiopathic arthritis
N Engl J Med. 2012 Dec 20;367(25):2385-95. doi: 10.1056/NEJMoa1112802
Golimumab treatment provides superior treatment of rheumatoid arthritis
Lancet. 2009 Jul 18;374(9685):210-21. Epub 2009 Jun 26